Lakefront Biotherapeutics NV (LKFT) stock
LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
$33.98+0.05 (+0.15%)
Close on Nov 13, 2026Market cap $2.24BP/E 6.3Yield –
Lakefront Biotherapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2020 it was -€159.95M, down 142.0% from the year before. The highest annual figure on record is €381.20M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -€159.95M | -142.0% |
| FY2019 | Dec 31, 2019 | €381.20M | – |
| FY2018 | Dec 31, 2018 | -€42.00M | – |
| FY2017 | Dec 31, 2017 | -€85.52M | – |
| FY2016 | Dec 31, 2016 | -€7.31M | – |
See a number that looks wrong?